Carregant...
Resisting resistance: Establishing new treatment options for CRPC patients
Overcoming drug resistance in castrate resistant prostate cancer requires improved understanding of mechanisms by which resistance occurs, as well as new treatment options. A recent study published in Nature (Li et al. 2015) examines the mechanism of abiraterone activity, and reveals the bioactivity...
Guardat en:
| Publicat a: | Cancer Biol Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910910/ https://ncbi.nlm.nih.gov/pubmed/26828765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1139271 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|